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Abstract The aim of this study was to evaluate the effect
of a 5-kHz repetition frequency of electroporating electric
pulses in comparison to the standard 1-Hz frequency on
blood flow of invasive ductal carcinoma tumors in Balb/C
mice. Electroporation was performed by the delivery of
eight electric pulses of 1,000 V cm-1 and 100 ls duration
at a repetition frequency of 1 Hz or 5 kHz. Blood flow
changes in tumors were measured by laser Doppler flow-
metry. Monitoring was performed continuously for 10 min
before application of the electric pulses as well as imme-
diately after application of the electric pulses for 40 min.
The delivery of electric pulses to tumors induced changes
in tumor blood flow. The reduction in blood flow started
after the stimulation and continued for the 40-min period of
observation. There was a significant difference in blood
flow changes 3 min after application of the electric pulses
at 1-Hz or 5-kHz repetition frequency. However, after
3 min the difference became nonsignificant. The findings
showed that the high pulse frequency (5 kHz) had an effect
comparable to the 1-Hz frequency on tumor blood flow
except at very short times after pulse delivery, when pulses
at 5 kHz produced a more intense reduction of blood flow.
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Introduction
Cell membrane electropermeabilization is a physical
method that uses short and intense electric pulses to
increase membrane permeability (Neumann et al. 1982)
and therefore increases the uptake of molecules such as
DNA, antibodies and drugs into the cells (Mir 2000).
Electrochemotherapy (ECT) is one application in which the
toxicity of a drug may locally be increased by increasing
the permeability of the target cells (Mir et al. 1991). Sev-
eral studies have provided evidence that ECT is an effec-
tive treatment for local tumors in patients with different
cancer types (Marty et al. 2006; Sersa et al. 2008a).
Experiments have provided sufficient data to demonstrate
that ECT with either bleomycin or cisplatin is highly
effective in the treatment of solid tumors.
In spite of its advantages, there are also some side
effects with ECT (Sersa et al. 2008a). In ECT, the pulse
delivery is usually painful for patients and causes a muscle
contraction. Several electric pulses are usually delivered,
with a repetition frequency of 1 Hz, which results in sev-
eral individual sensations and muscle contractions (Zu-
panic et al. 2007).
To reduce the number of individual muscle contractions,
use of a pulse frequency larger than the frequency of
tetanic contraction has been suggested (Miklavcic et al.
2005). It was reported that a train of eight electric pulses at
1 Hz results in eight muscle contractions, while the same
number of pulses results in only one single muscle con-
traction when pulses are delivered at 5 kHz. Increasing the
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repetition frequency of the pulses lowers the number of
contractions, whereas clinical effectiveness remains at the
same level as that of the pulses delivered at 1 Hz (Marty
et al. 2006). This means that high electric pulse repetition
frequency not only shortens the therapy session but also
allows the ECT to be better tolerated by the patient in
comparison to the standard pulses at 1 Hz (Zupanic et al.
2007).
It has been shown that the antitumor effectiveness of
ECT is mainly related to increased drug uptake caused by
electroporation (Poddevin et al. 1991; Sersa et al. 2006;
Kanthou et al. 2006). In vivo, electrical pulses have other
effects, such as a transient and reversible reduction of tis-
sue blood flow (Sersa et al. 1998, 1999, 2006; Gehl et al.
1999, 2002; Kanthou et al. 2006). Reduction of tumor
blood flow may result in trapping of the drug in the tumors,
thus providing a longer time for the drug to act (Mir 2006).
Modification of the blood flow could be particularly ben-
eficial for intratumoral drug administration as this would
decrease the drug washout from the tumor (Mir 2006).
In vitro studies have reported that with an increased
repetition frequency (up to 8.3 kHz) uptake of nonperma-
nent molecules might stay at similar levels, but the field
strength necessary to achieve optimal uptake had to be
increased (Pucihar et al. 2002). However, under usual
conditions, ECT with high repetition frequencies inhibited
tumor growth and had similar treatment efficiency
regardless of the pulse frequency used, 1 Hz or 5 kHz, in
vivo in mice. It was demonstrated that increasing the rep-
etition frequency of the electric pulses from the standard
1 Hz to 5 kHz was also successful in human clinical cases
(Miklavcic et al. 2005; Marty et al. 2006; Snoj et al. 2007).
Gehl et al. (2002) analyzed the influence of the voltage and
the duration of the pulses on the vascular lock. To the best
of our knowledge, there has been no experiment on the
tumor perfusion changes as a function of the repetition
frequency of the electric pulses.
The purpose of present study was to investigate the
changes in tumor perfusion after application of electric
pulses at 1-Hz and 5-kHz repetition frequencies.
Materials and Methods
Mice and Tumors
Healthy female Balb/C mice, 6–8 weeks of age, were
purchased from the Pasteur Institute (Tehran, Iran). They
were kept at 22C temperature with a natural day/night
cycle for 10 days for adaptation. Spontaneous mouse
mammary tumor (SMMT), i.e., an invasive ductal carci-
noma, was transplanted by implanting a 4-mm3 fragment
into the right flank of anesthetized mice. Approximately
2 weeks after tumor transplantation, when the largest
tumor diameter exceeded 5 mm (measured by caliper), the
animals were randomly divided into experimental and
control groups (15 animals for the control group and for
each of the experimental groups).
Electroporation Protocol
Two flat, parallel, stainless-steel plate electrodes were
placed at the opposite sides of the tumors to deliver the
electric pulses. Conductive gel was used to assure good
contact between electrodes and skin. Eight square-wave
electric pulses of 1,000 V cm-1, 100 ls duration, at repe-
tition frequencies of 1 Hz or 5 kHz, were delivered to the
mice using an ECT-SBDC device for electroporation that
was designed in the Electromagnetics Laboratory of the
Medical Physics Department of Tarbiat Modares Univer-
sity (Tehran, Iran).
Laser Doppler Flowmetry
Relative blood flow of tumors was measured using laser-
Doppler flowmetry (MBF3; Moor Instrument, Axminster,
UK) by inserting the probes (MP3/MP3b, hypodermic
stainless-steel tube) into the tumor via a small superficial
incision on the skin (Jarm et al. 2002). Laser-Doppler
flowmetry is widely used for the assessment of microvas-
cular blood perfusion in tissue, and the operating principles
are described, e.g., in Shepherd and Oberg (1989). The
measured microvascular blood flow was the product of the
mean red blood cell velocity and the mean red blood cell
concentration in the volume of tissue being monitored.
Microvascular blood flow is expressed in relative units
called ‘‘blood perfusion units.’’
The output of the electroporation device was connected
to a personal computer via an RS232 connector. Micro-
vascular blood flow signals were stored on the computer at
a frequency sample rate of 40 Hz. Mean flow values over
5 min (Fig. 1) or 1 min (Fig. 2) were calculated using the
Winsoft program (laser Doppler perfusion measure,
V3.0.8; Moor Instruments).
All experimental measurements were conducted on
anesthetized mice to minimize discomfort and movements.
Mice were anesthetized by means of intraperitoneal
administration of 0.01 ml/g body weight of the following
mixture: 0.5 ml of ketamine (100 mg/ml; Virbac, Carros,
France), 0.5 ml of xylazine (2%; Bayer HealthCare, Le-
verkusen, Germany) and 4 ml of NaCl.
Anesthetized mice were placed on a heating pad to
maintain the body temperature at a constant level. Rectal
and surface temperature probes were used to control the
temperature during the experiments. Rectal temperatures
were kept at 37 ± 0.5C by adjusting the heating pad
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temperature. The ambient temperature was 22–24C during
the experiments.
Approximately 5 min after anesthesia, the laser-Doppler
flowmetry probe was inserted into the tumor after making a
small superficial incision in the skin. Data were acquired
while the probe was strengthened in the tissue. After initial
rest and stabilization (15 min), baseline recordings were
performed for 10 min. Then, the electrodes were placed as
described above and the electric pulses delivered to the
tumors. The flowmetric recording was continued after the
pulses for at least 40 min. In the control group, the same
procedure was performed; however, no electric pulse was
delivered. Special care was taken during the measurements
to minimize the movements of probes and mice during
acquisition. Average blood flow values over 5 min before
electric pulse delivery and at 0, 5, 10, 15, 20, 25, 30, 35 and
40 min after the electric pulses were calculated. Blood flow
changes after the pulses were normalized with respect to
the average blood flow obtained during the 10 min before
time zero. Thus, blood flows were expressed as percentages
of the preexposure blood flow.
Data Analysis
The average perfusion changes due to treatment versus the
electrical pulse duration were plotted for each group of
mice. All data were tested for normality of distribution.
ANOVA and unpaired Student’s t test were used to eval-
uate the statistical significance of differences between the
experimental and control groups. P \ 0.05 was considered
significant in the statistical tests.
Results
In this study, laser-Doppler flowmetry was used to evaluate
the blood flow variations induced by application of electric
pulses to tumors in vivo. Tumor blood flow was measured
continuously from 10 min before application of the electric
pulses up to 40 min after the electric pulses. In this way,
we were able to monitor even short-lived and/or small
changes in blood flow.
Eight pulses of 100 ls duration were delivered at a
repetition frequency of 1 Hz or 5 kHz. The repetition fre-
quency of the pulses was changed through adjustment of
the delay between two consecutive pulses in the train.
The changes in tumor blood flow as a function of the
frequency repetition are shown in Fig. 1. The curves in
Fig. 1 represent the blood flow changes in control and in
the groups treated at 1 Hz and 5 kHz and monitored for
40 min after pulse delivery.
There was a rapid reduction in blood flow immediately
after application of the pulses. Minimal blood flow level
was reached at 2 min after pulse delivery. The rapid
reduction was followed by a gradual reperfusion. The
partial reperfusion reached a peak around 10–20 min.
There was a difference between the changes in tumor blood
flow after application of electric pulses at 1 Hz or 5 kHz.
At the repetition frequency of 5 kHz, the reduction in
tumor perfusion was higher than at the frequency of 1 Hz
(Fig. 2). The difference was significant at 3 min after pulse
delivery, and the difference in the perfusion between the
two repetition frequencies completely disappeared after
10 min, remaining similarly lower with respect to the
controls. The tumor blood flow in the control group showed
no significant changes during the same monitoring period.
Results of the t test revealed significant differences in
blood flow between control and each experimental group
immediately after application of electric pulses (P \ 0.05).
These differences remained significant until the end of the
monitoring, 40 min after application of the pulses. The
difference between the groups treated with the electric
pulses at 1 Hz and 5 kHz was significant (P \ 0.05) only





















Time after electric pulses(min)
Control (n=15)
Electric pulses 1Hz (n=15)
Electric pulses 5kHz (n=15)
Fig. 1 Blood flow changes (mean flow values over 5 min) at 5-min






















Time after electric pulses(min)
Control (n=15)
Electric pulses 1Hz (n=15)
Electric pulses 5kHz (n=15)
Fig. 2 Blood flow changes (mean flow values over 1 min) during the
initial period (10 min) after the pulses (* P \ 0.05)
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Discussion
ECT is an efficient local treatment of cutaneous and sub-
cutaneous tumors. However, muscle contractions and
painful sensations are unpleasant effects during electric
pulse delivery (Sersa et al. 2008a). To reduce the painful
sensations of the treatment, pulses delivered at a repetition
frequency of 1 Hz may be replaced by pulses delivered at
5 kHz, while preserving the efficiency of the treatment
(Miklavcic et al. 2005).
It is now a well-documented fact that electroporation has
a vascular disrupting action (Gehl et al. 2002; Kanthou
et al. 2006). Electroporation-based therapies cause changes
in blood flow and vascular permeability (Gehl et al. 2002;
Sersa et al. 2008b). The duration of the vascular lock
consequently starves the tumor of oxygen and nutrients and
contributes to the antitumor effects of ECT.
Although the vascular effects of electroporation have
been shown by different techniques (Sersa et al. 2008a),
they have not yet been monitored in real time quantita-
tively. Therefore, it seemed useful to evaluate the effect of
electric pulses of different frequencies on blood flow of
tumors in real time. In this study, the effects of the 1-Hz
and 5-kHz pulse frequencies were investigated on the
blood flow of a mouse tumor model.
Our study demonstrates that application of electric
pulses induces significant changes in tumor blood flow
(Fig. 1). Our results were consistent with those of previous
investigations that reported a reduction in blood flow after
application of electric pulses (Sersa et al. 1999). We
observed an immediate reduction in blood flow after
application of electric pulses that gradually (but incom-
pletely) recovered for the 40 min monitoring period. The
immediate reduction in tumor blood flow at 5 kHz was
higher than the reduction at 1 Hz during the initial period
following pulse delivery. Our data also showed that at
longer times the higher pulse frequency (5 kHz) had effects
on tumor blood flow comparable to those observed at 1 Hz.
Our results are thus in agreement with those of clinical
studies showing no difference in the effectiveness of ECT
using repetition frequencies of the applied pulses of 1 Hz
or 5 kHz (Marty et al. 2006; Snoj et al. 2007).
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